We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Eating Flavonoids-Rich Foods May Protect Men Against Parkinson’s

By LabMedica International staff writers
Posted on 17 Apr 2012
Men who eat flavonoid-rich foods such as apples, berries, tea, and red wine considerably reduce their risk of developing Parkinson’s disease (PD).

Published April 4, 2012, in the journal Neurology, the study’s findings supplement the growing evidence that regular consumption of some flavonoids can have a distinct effect on health. More...
Recent studies have shown that these compounds can provide protection against a wide range of diseases including heart disease, hypertension, various cancers, and dementia.

This latest study, conducted by investigators from by Harvard University (Cambridge, MA, USA) and the University of East Anglia (UEA; Norwich, UK) is the first study in humans to demonstrate that flavonoids can protect neurons against diseases of the brain such as Parkinson’s.

Approximately 130,000 men and women were enrolled in the study. More than 800 had developed PD within 20 years of follow-up. After a comprehensive analysis of their diets and adjusting for age and lifestyle, male participants who ate the most flavonoids were shown to be 40% less likely to develop the disease than those who ate the least. No similar association was found for total flavonoid intake in women.

The research was led by Dr. Xiang Gao of Harvard School of Public Health in collaboration with Prof. Aedin Cassidy, from the department of nutrition, Norwich Medical School at UEA. “These exciting findings provide further confirmation that regular consumption of flavonoids can have potential health benefits,” said Prof. Cassidy. “This is the first study in humans to look at the associations between the range of flavonoids in the diet and the risk of developing Parkinson’s disease and our findings suggest that a subclass of flavonoids called anthocyanins may have neuroprotective effects.”

Dr. Gao said, “Interestingly, anthocyanins and berry fruits, which are rich in anthocyanins, seem to be associated with a lower risk of Parkinson’s disease in pooled analyses. Participants who consumed one or more portions of berry fruits each week were around 25% less likely to develop Parkinson’s disease, relative to those who did not eat berry fruits. Given the other potential health effects of berry fruits, such as lowering risk of hypertension as reported in our previous studies, it is good to regularly add these fruits to your diet.”

Flavonoids are a group of naturally occurring, bioactive compounds found in many plant-based drinks and foods. In this study, the key protective effect was from higher intake of anthocyanins, which are present in berries and other fruits and vegetables including eggplant, blackcurrants, and blackberries. Those who consumed the most anthocyanins had a 24 per cent reduction in risk of developing PD and strawberries and blueberries were the top two sources in the diet in the United States.

The results must now be validated by other large epidemiologic studies and clinical trials, according to the investigators. PD is a progressive neurologic condition affecting one in 500 people, which equates to 127,000 people in the United Kingdom. There are few effective drug therapies available.

Dr. Kieran Breen, director of research at Parkinson’s UK (London), said, “This study raises lots of interesting questions about how diet may influence our risk of Parkinson’s and we welcome any new research that could potentially lead to prevention. “While these new results look interesting there are still a lot of questions to answer and much more research to do before we really know how important diet might be for people with Parkinson’s.”

Related Links:

Harvard University
University of East Anglia
Parkinson’s UK



New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
ESR Analyzer
TEST1 2.0
New
Rapid Test Reader
DIA5000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The cell-based tests bring artificial intelligence to transplant outcome care (Photo courtesy of iStock)

AI-Enhanced Cell-Based Blood Tests to Improve Predictive Accuracy for Complex Transplant Outcomes

Managing immunosuppressive drugs in transplant patients is a delicate challenge. Insufficient medication can lead to rejection, which may be cell- or antibody-mediated, while excess immunosuppression raises... Read more

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: PD-1 protein blockade is the standard treatment for advanced melanoma among the different types of immunotherapy (Photo courtesy of 123RF)

Precision Tool Predicts Immunotherapy Treatment Failure in Melanoma Patients

Melanoma, though accounting for only about 4% of skin tumors, is the deadliest form of skin cancer due to its high potential to metastasize. While immunotherapy, especially PD-1 protein blockade, has revolutionized... Read more

Pathology

view channel
Image: A saliva test can help predict future metabolic health concerns including diabetes and obesity (Photo courtesy of 123RF)

Saliva Test to Enable Early Detection of Diabetes and Obesity

Type 2 diabetes affects about 400 million people globally and is typically diagnosed through elevated blood glucose levels. However, conditions like insulin resistance and hyperinsulinemia may begin developing... Read more

Industry

view channel
Image: Alzheimer’s Association has released its first clinical practice guideline for blood-based biomarker tests (Photo courtesy of Alzheimer’s Association)

New Clinical Guidelines Recommend Use of Blood Tests Instead of Brain Scans for Alzheimer’s Diagnosis

Alzheimer’s disease is a progressive neurodegenerative condition that remains challenging to diagnose early and accurately, particularly in individuals with cognitive impairment. Despite the availability... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.